Save Billions or Stick With Humira? Drug Brokers Engage in Blatant Price Gouging as FTC Investigates and Some Health Plans Rebel
Demand that state legislators investigate pharmacy benefit manager price-gouging for biologics like Humira when cheaper biosimilars exist
Read more...